Blair William & CO Arcturus Therapeutics Holdings Inc. Transaction History
Blair William & CO
- $33.5 Billion
- Q4 2024
A detailed history of Blair William & CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Blair William & CO holds 16,735 shares of ARCT stock, worth $265,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,735
Previous 17,830
6.14%
Holding current value
$265,417
Previous $413,000
31.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARCT
# of Institutions
171Shares Held
25MCall Options Held
219KPut Options Held
157K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$74.4 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$42 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$32.8 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$32.8 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$30.7 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $422M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...